Designing Growth Strategies is in our DNA

AI in Real-World Evidence Market Size, Share & Industry Analysis, By Component (Software/Platform and Services), By Deployment (Cloud-Based, On-Premise & Hybrid), By Technology (Machine Learning & Deep Learning, NLP/Generative AI), By Application (Cohort Discovery & Patient Stratification, Endpoint Extraction & NLP, Comparative Effectiveness & Outcomes Research, Safety Surveillance & Signal Detection, Regulatory & HTA Evidence Generation), By End User (Pharmaceutical & Biotechnology Companies, CROs/Real-world Data Vendors, Payers, Healthcare Providers), and Regional Forecast, 2026-2034

Last Updated :July 14, 2026 | Format:PDF | Report ID: 118102

 

Request a Sample

man icon
Mail icon
Mail icon
What's included in this sample
Market segmentation:

Detailed and granular segments, regions and countries covered

Scope of research:

Comprehensive quantitative data and qualitative insights

Report structure:

Representation of data and insights in the report

Key findings:

Market Estimates, Growth Rate, Largest Region and Segment

Index:

Overview of data and insights in each chapter

Research Methodology:

Summary of research processes adopted

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 164